Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium-activated chloride channels are membrane proteins crucial for epithelial Cl^− and water secretion. The principal channel in the intestinal epithelium is Anoctamin 1 (TMEM16A), which responds to increases in intracellular Ca^2+ by allowing chloride ions to exit epithelial cells into the intestinal lumen. This drives water movement by osmosis, aiding in hydration of the intestinal tract and mucus layer. TMEM16A is highly expressed in the intestine (notably in epithelial and interstitial cells of Cajal), as well as in airway, sensory, and other tissues. Dysregulation contributes to diseases such as secretory diarrhea (overactivation) and cystic fibrosis (potentially beneficial compensation for defective CFTR). TMEM16A is a validated therapeutic target for both inhibitors (to treat secretory diarrhea) and activators (as an alternative therapeutic approach in cystic fibrosis).
Inhibitors: Block Ca^2+-activated gating of the channel, preventing anion (Cl^−) flux and thereby reducing intestinal fluid secretion. Activators: Elevate cytoplasmic Ca^2+ or directly activate the channel to promote chloride and fluid secretion, useful in cystic fibrosis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-activated chloride channel protein 1 (TMEM16A (also known as ANO1)).